Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans
JCI Insight · 2026
DOI: 10.1172/jci.insight.198360 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Huidong Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Georgia Cancer Center, Medical College of Georgia, and. Hauptthemen laut MEDLINE: Myelopoiesis, Monocytes, Neutrophils, Cyclophosphamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH Office of the Director.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Cytotoxic chemotherapy primarily targets rapidly proliferating cancer cells but also depletes normal myeloid cells. The resulting cell loss triggers reactive myelopoiesis, a compensatory process in which hematopoietic stem and progenitor cells in the bone marrow (BM) regenerate myeloid lineages. We previously showed that the alkylating agent cyclophosphamide (CTX) induces myelopoiesis, leading to the expansion of immunosuppressive monocytes in mice. However, the molecular features and clinical relevance of these cells remain poorly understood. Here, we report the emergence of immunosuppressive monocytes in the peripheral blood of lymphoma patients receiving CTX-containing chemotherapy. To gain mechanistic insight into CTX-induced myelopoiesis, we performed single-cell RNA sequencing (scRNA-seq) and assay for transposase-accessible chromatin using sequencing (ATAC-seq) on BM monocytes from CTX-treated mice. These analyses revealed a heterogeneous monocyte population and demonstrated that CTX skews myelopoiesis toward the generation of neutrophil-like monocytes (NeuMo). Moreover, CTX-induced NeuMo cells, enriched within the CXCR4 + CX3CR1 – monocyte subset, exhibited potent T cell–suppressive activity. Using the NeuMo gene signature, reanalysis of public scRNA-seq datasets identified a transcriptionally similar monocyte subset in chemotherapy-treated cancer patients. Collectively, our findings suggest that the expansion of NeuMo cells following chemotherapy represents a conserved immunoregulatory feedback mechanism with potential impact on tumor response to chemoimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Georgia Cancer Center, Medical College of Georgia, and.
- Immunology Center of Georgia, Augusta University, Augusta, Georgia, USA.
Förderung
- NCI NIH HHS
- NIH Office of the Director
Zitieren
APA
Shi, H., Ding, Z. C., Okoko, O. D., Wang, X., Zhou, G., Ye, Y., Gazi, M. Y., Brandle, C., Pei, L., Pacholczyk, R., Hedrick, C. C., Bryan, L. J., & Zhou, G. (2026). Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans. JCI Insight. https://doi.org/10.1172/jci.insight.198360
Vancouver
Shi H, Ding ZC, Okoko OD, Wang X, Zhou G, Ye Y, et al. Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans. JCI Insight. 2026. doi:10.1172/jci.insight.198360
BibTeX
@article{Shi2026,
author = {Shi, Huidong and Ding, Zhi-Chun and Okoko, Ogacheko D and Wang, Xin and Zhou, George and Ye, Yan and Gazi, Md Yeashin and Brandle, Caitlin and Pei, Lirong and Pacholczyk, Rafal and Hedrick, Catherine C and Bryan, Locke J and Zhou, Gang},
title = {Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.198360}
}
EUVIMED